EHC Encompass Health Corporation
Healthcare$104.96+0.49%ClosedMarket Cap: $10.41B
As of 2026-05-25
Valuation
P/E (TTM)
19.06
PEG
0.79
P/B
4.13
P/S
1.72
EV/EBITDA
9.03
DCF Value
$36.47
FCF Yield
4.5%
Div Yield
0.7%
Margins & Returns
Gross Margin
58.8%
Operating Margin
17.9%
Net Margin
10.0%
ROE
25.3%
ROA
8.3%
ROIC
13.3%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $1.59B | 48.4% | $301.6M | $194.5M | $— | $0.19 |
| Q4 null | $1.54B | 95.8% | $283.4M | $146.1M | $— | $0.19 |
| FY null | $5.94B | 95.7% | $1.05B | $566.2M | $— | $0.70 |
| Q3 null | $1.48B | 46.9% | $243.6M | $126.5M | $— | $0.17 |
| Q2 null | $1.46B | 43.0% | $259.1M | $142.1M | $— | $0.17 |
| Q1 null | $1.46B | 43.3% | $267.0M | $151.5M | $— | $0.17 |
| Q4 null | $1.41B | 41.7% | $232.3M | $120.9M | $— | $0.17 |
| FY null | $5.37B | 41.6% | $864.5M | $455.7M | $— | $0.62 |
| Q3 null | $1.35B | 41.3% | $209.1M | $108.2M | $— | $0.15 |
| Q2 null | $1.30B | 41.7% | $215.6M | $114.1M | $— | $0.15 |
| Q1 null | $1.32B | 41.5% | $207.5M | $112.5M | $— | $0.30 |
| Q4 2023 | $1.25B | 41.1% | $444.8M | $87.6M | $0.86 | $0.30 |